MedPath

Precedex

Brand Name: Precedex

Generic Name: Dexmedetomidine (as hydrochloride)

Active
Registration Number

DR-XY32202

Dosage Form

Concentrate For Intravenous Infusion

Issuance Date

July 1, 2024

Expiry Date

August 21, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mcg/mL (200 mcg/2 mL)
Packaging2 mL USP Type I clear and colorless glass vial (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Hypnotic / Sedative
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Dexmedetomidine (as hydrochloride)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform